Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) Sees Significant Growth in Short Interest

Kyowa Kirin Co., Ltd. (OTCMKTS:KYKOF) was the target of a large increase in short interest in the month of March. As of March 15th, there was short interest totalling 539,400 shares, an increase of 37.0% from the February 28th total of 393,700 shares. Based on an average trading volume of 1,000 shares, the short-interest ratio is presently 539.4 days.

Kyowa Kirin Price Performance

Kyowa Kirin stock remained flat at $14.75 during trading on Tuesday. Kyowa Kirin has a 1-year low of $12.32 and a 1-year high of $22.21. The company has a 50 day moving average price of $13.99 and a two-hundred day moving average price of $16.10.

Kyowa Kirin Company Profile

Kyowa Kirin Co, Ltd. engages in the research, development, manufacturing, marketing, and import/export of pharmaceuticals for oncology, nephrology, central nervous system, and immunology therapeutic areas in Japan, the United States, rest of the Americas, Europe, Asia, and internationally. Its products include ALLELOCK, an antihistamine agent for patients with various types of allergies; CONIEL, a calcium channel blocker for hypertension and angina pectoris; Crysvita, a recombinant human monoclonal IgG1 antibody against the phosphaturic hormone fibroblast growth factor 23; ESPO, a glycoprotein and human erythropoietin; NESP, an erythropoiesis stimulating agent; and GRAN, a human colony-stimulating factor.